Questions About a Clinical Trial Evaluating the Addition of Cetuximab to Definitive Chemoradiation Therapy With Paclitaxel and Cisplatin for Patients With Esophageal Cancer-Reply.
Suntharalingam, Mohan
Questions About a Clinical Trial Evaluating the Addition of Cetuximab to Definitive Chemoradiation Therapy With Paclitaxel and Cisplatin for Patients With Esophageal Cancer-Reply. [electronic resource] - JAMA oncology 06 2018 - 888-889 p. digital
Publication Type: Letter; Comment
2374-2445
10.1001/jamaoncol.2018.0242 doi
Cetuximab
Chemoradiotherapy
Cisplatin
Esophageal Neoplasms
Humans
Paclitaxel
Questions About a Clinical Trial Evaluating the Addition of Cetuximab to Definitive Chemoradiation Therapy With Paclitaxel and Cisplatin for Patients With Esophageal Cancer-Reply. [electronic resource] - JAMA oncology 06 2018 - 888-889 p. digital
Publication Type: Letter; Comment
2374-2445
10.1001/jamaoncol.2018.0242 doi
Cetuximab
Chemoradiotherapy
Cisplatin
Esophageal Neoplasms
Humans
Paclitaxel